Cartesian Therapeutics GAAP EPS of -$10.50, revenue of $5.84M
Cartesian Therapeutics GAAP EPS of -$10.50, revenue of $5.84M
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
CRISPR Therapeutics GAAP EPS of -$1.43 misses by $0.03, revenue of $0.5M misses by $24.67M
SeekingAlpha
-
Verve Therapeutics GAAP EPS of -$0.59 beats by $0.12, revenue of $5.7M beats by $3.45M
SeekingAlpha
-
Beam Therapeutics GAAP EPS of -$1.21 beats by $0.23, revenue of $7.41M misses by $7.25M
SeekingAlpha
-
Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
SeekingAlpha